Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment
Prospective Multicenter Non-interventional Study in Patients With Knee or Hip Osteoarthritis Having a Theraflex Treatment
The main purpose of this study is to evaluate how a long-term treatment with Theraflex during
 64 weeks affects pain intensity in the affected knee or hip joint, the activity in daily
 living, the quality of life and patient satisfaction with treatment.
Other information that is planned for evaluation in this study includes consumption of
 Theraflex, intake of analgesics for joint pain relief and description of basic patient
 characteristics such as age, weight and body mass index and others.
Inclusion Criteria:

 -  Patients 45 to 75 years with Hip or Knee OA stage I to III

 -  Patient started current treatment with Theraflex not more than 2 weeks prior to
 inclusion into the study

 -  Personally signed and dated informed consent

 Exclusion Criteria:

 -  Patients participating in an investigational program with interventions outside of
 routine clinical practice

 -  Patients with Hip or Knee OA stage 0 or stage IV

 -  Patients who have both Hip and Knee OA and OA of any other location

 -  Contraindications for use of Theraflex in accordance with approved label(known
 hypersensitivity, severe chronic renal failure)

 -  Females who are pregnant or breastfeeding

 -  Patients who completed a treatment with Theraflex or another combination of Gl+ Ch
 less than 5 months before start of the current treatment

 -  Patients who completed intra-articular corticosteroids treatment in the last 3 months
 to exclusion criteria

 -  Patients who completed hyaluronic injections of the lower limbs in the last 6 months